John A. Sedor
Overview
John A. Sedor received an average of $2M in total compensation, including $502K in salary, at Pernix Therapeutics Holdings between 2016 and 2017.
Source: SEC filing on April 9, 2018.
Related executives
We found ten more executives who work or worked at Pernix Therapeutics Holdings.
Graham Miao
Pernix Therapeutics Holdings
Chief Financial Officer
Kenneth Piña
Pernix Therapeutics Holdings
Secretary
Sanjay Patel
Pernix Therapeutics Holdings
Chief Financial Officer
Doug Drysdale
Pernix Therapeutics Holdings
Chief Executive Officer
Rick Shalaby
Pernix Therapeutics Holdings
Senior Vice President of Commercial Operations
Terence Novak
Pernix Therapeutics Holdings
Chief Operating Officer
David Becker
Pernix Therapeutics Holdings
Chief Financial Officer
Charles Hrushka
Pernix Therapeutics Holdings